Search

Your search keyword '"Afkhami, Michelle"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Afkhami, Michelle" Remove constraint Author: "Afkhami, Michelle" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
182 results on '"Afkhami, Michelle"'

Search Results

5. Diversity of Seed Endophytes: Causes and Implications

9. Diversity of Seed Endophytes: Causes and Implications

12. A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report

15. Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL

17. NUTM1-rearranged Carcinoma of the Thyroid: A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3-NUTM1 Fusions

18. Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome.

22. Preparing for the Unexpected: Recommendations for Returning Secondary Findings in Late-Stage Cancer Care

23. Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients.

24. Determination of age-dependent bone marrow normocellularity.

25. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.

27. WT1 -mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens

28. Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia

32. Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma

33. Allelopathy‐selected microbiomes mitigate chemical inhibition of plant performance.

39. High Response Rates and Transition to Transplant after Novel Targeted and Cellular Therapies in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia with Philadelphia‐Like Fusions

41. Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with Measurable Residual Disease and the Impact of Conditioning Regimen and Graft-Versus-Host Disease Prophylaxis Intensity: A Single Center Retrospective Analysis

42. Outcome of Patients Undergoing Hematopoietic Cell Transplantation for TP53-Mutated Acute Leukemias and MDS: Effect of Conditioning and GvHD Prophylaxis Regimens Intensity

43. Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions

44. Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

45. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)

47. The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

50. Hydrology shapes microbial communities and microbiome‐mediated growth of an Everglades tree island species.

Catalog

Books, media, physical & digital resources